Shapira O M, Aldea G S, Treanor P R, Chartrand R M, DeAndrade K M, Lazar H L, Shemin R J
Department of Cardiothoracic Surgery, Boston Medical Center, Massachusetts 02118, USA.
Ann Thorac Surg. 1998 Mar;65(3):724-30. doi: 10.1016/s0003-4975(97)01431-8.
Despite recent advances in blood conservation techniques, up to 30% to 80% of patients undergoing open heart operations require allogeneic blood transfusions. A prospective, randomized study was performed to test the effect of lowering cardiopulmonary bypass prime volume (as an additional component of an integrated blood conservation strategy) on clinical outcome and allogeneic blood transfusion.
One hundred fourteen patients undergoing open heart operations were randomized to either full prime (FP) volume (1,400 mL of Plasmalyte solution) or reduced prime (RP) volume (600 to 800 mL). The reduction of prime volume was achieved by slowly draining the cardiopulmonary bypass circuit into a cell-saving device before the initiation of bypass. Firm transfusion thresholds were observed.
There were no significant differences between the groups with respect to baseline characteristics, body surface area, type and urgency of the procedures, perfusion technique, and hematologic profile. Mortality (FP, 1.7%; RP, 0%; p approximately 1.0) and overall morbidity (FP, 28.1%; RP, 22.8%; p = 0.53) were similar. However, transfusion requirements were significantly lower in the RP group: total donor exposure, 3.8 +/- 10.1 versus 1.0 +/- 2.4 units (p = 0.044); percentage of patients transfused, 54% (n = 31) versus 35% (n = 20) (p = 0.036). Twenty-four-hour chest tube drainage was similar: 455 +/- 223 mL for FP versus 472 +/- 173 mL for RP (p = 0.66). The lowest hematocrit on bypass was significantly higher in the RP group: 29.3% +/- 4% versus 26.3% +/- 5.3% (p = 0.009).
Lowering cardiopulmonary bypass prime volume resulted in a significant decrease in allogeneic blood product use. Because postoperative 24-hour chest tube drainage was similar in both groups, and hematocrit during bypass was higher in the RP group, the reduction in allogeneic blood transfusions appears to be related to a decrease in prime-induced hemodilution. This technique is effective, simple, and safe. It therefore should be strongly considered for patients undergoing operations using normothermic or near-normothermic cardiopulmonary bypass who are at high risk for allogeneic blood transfusion.
尽管血液保护技术近来有所进展,但仍有30%至80%的心脏直视手术患者需要异体输血。开展了一项前瞻性随机研究,以检验降低体外循环预充量(作为综合血液保护策略的一个附加组成部分)对临床结局和异体输血的影响。
114例接受心脏直视手术的患者被随机分为全量预充(FP)组(1400 mL血浆代用品溶液)或减量预充(RP)组(600至800 mL)。在体外循环开始前,通过将体外循环回路中的血液缓慢引流至血液回收装置来实现预充量的减少。严格遵守输血阈值。
两组在基线特征、体表面积、手术类型和紧急程度、灌注技术及血液学指标方面无显著差异。死亡率(FP组1.7%,RP组0%;p约为1.0)和总体发病率(FP组28.1%,RP组22.8%;p = 0.53)相似。然而,RP组的输血需求显著更低:总的供血暴露量,3.8±10.1单位对1.0±2.4单位(p = 0.044);接受输血的患者百分比,54%(n = 31)对35%(n = 20)(p = 0.036)。24小时胸管引流量相似:FP组为455±223 mL,RP组为4 +72±173 mL(p = 0.66)。RP组体外循环期间的最低血细胞比容显著更高:29.3%±4%对26.3%±5.3%(p = 0.009)。
降低体外循环预充量可显著减少异体血制品的使用。由于两组术后24小时胸管引流量相似,且RP组体外循环期间的血细胞比容更高,异体输血的减少似乎与预充引起的血液稀释的降低有关。该技术有效、简单且安全。因此,对于接受常温或近常温体外循环手术且异体输血风险高的患者,应强烈考虑采用该技术。